GlassScriptPhysician profile
David M Hodges
NPI 1881734168
$2,470.95
in general payments reported to CMS, 2019-2025
24 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $406 · 2021: $578 · 2022: $397 · 2023: $227 · 2024: $159 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $408.62 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $389.71 | 2019-2023 | |
| Amgen INC. | $387.74 | 2020-2025 | Repatha |
| Cvrx, INC. | $193.69 | 2019-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $156.27 | 2019-2025 | |
| Novo Nordisk INC | $151.57 | 2021-2025 | Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $137.54 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.91 | 2019-2022 | |
| Pfizer INC. | $94.81 | 2023-2025 | |
| Baxter Healthcare | $83.56 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $69.96 | 2019-2020 | |
| Lilly USA, LLC | $34.82 | 2024-2025 | Zepbound, Mounjaro |
| Medicomp INC | $32.00 | 2025 | Telepatch Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.61 | 2021-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $29.65 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $25.57 | 2019 | |
| Preventice Services, LLC | $18.46 | 2019 | |
| Medtronic, INC. | $16.48 | 2023 | Micra |
| Irhythm Technologies, INC. | $13.47 | 2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $13.09 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $12.40 | 2025 | Rhythm Express |
| E.R. Squibb & Sons, L.L.C. | $12.25 | 2020 | |
| Lundbeck LLC | $12.22 | 2020 | |
| Horizon Therapeutics Plc | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.